Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibodies Regulatory News (FAB)

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes
Get Live Data
12.75    0.00 (0.00%)
Bid:
12.00
Ask:
13.50
Spread: 1.50 (12.50%)
Market Cap: £16.25m
FAB Live PriceLast checked at - London Stock Exchange

Intraday Fusion Antibodies Share Chart

Acquisition

11 Jun 2008 07:00

RNS Number : 4227W
Fabian Romania Limited
11 June 2008
 

11 June 2008

Fabian Romania and SCD announce residential development joint venture and acquisition of first two sites

AIM listed Fabian Romania Limited ("Fabian") and Hungarian real estate developer SCD Group ("SCD") are pleased to announce the formation of 50/50 joint venture, SCD Fabian OSM S.A. ("Joint Venture"), to develop residential property projects in western Romania

The Joint Venture has reached agreement to buy two residential development sites in western RomaniaThe projects will comprise two residential developments, one of 388 residential apartments in Oradea and the other being 165 residential apartments in Satu Mare. Both cities are located close to the Hungarian borderbenefitting from the growth in cross-border trade and investment. SCD Group will act as developer on both projects and Fabian has signed joint venture and development management agreements with SCD to this effect.

The purchase price for the two sites was 2.5 million (excluding VAT) with an additional equity requirement of 3.75 million, adding up to a total investment of 6.25 million, contributed by Fabian and SCD in equal proportions.

The Oradea site comprises 33,862 square metres and comes with outline planning consent (PUZ) to build 24,100 square metres of residential apartments and 404 parking spaces. Detailed planning and construction consents will be required from local planners and are expected to be received by the third quarter of 2008The Satu Mare site is 6,700 square metres and already has a building permit to construct 12,400 square metres of residential apartments with 103 parking spaces. Construction work on both sites is forecast to begin in the first quarter of 2009 with practical completion anticipated in the first half of 2011 for the Satu Mare development and in the third quarter of 2012 for the Oradea development.

Fabian and SCD both aim to identify further development opportunities for the Joint Venture with a focus on secondary cities in western Romania.

These two acquisitions form part of Fabian's strategy to invest in and develop residential schemes in the fast growing secondary cities, particularly in western Romania. The first such scheme was an investment in Timisoara, where Fabian is developing 350 residential apartments.

Commenting on the transaction, Mark OwenProperty Director of Fabian Capital, the investment adviser to Fabian said: 

"We are delighted that Fabian has reached agreement with SCD Group,  a strong partner to co-invest alongside in two new residential schemes and thereby build further on its residential strategy. SCD Group has considerable development experience particularly in Eastern Europe and is the ideal partner for Fabian."

"Both cities are experiencing strong growth through property and business investments. Oradea is an attractive historic city and Satu Mare has an industrial background. Both cities will benefit from a new supply of modern design-led, quality constructed developments."

The partnership with Fabian is in line with SCD's regional expansion strategyto team up with experienced professional property investors when entering new development markets. Mike BorisSCD's Chief Transaction Officer commented: "Fabian has unparalleled expertise on the Romanian property market. We are pleased to announce our joint venture with Fabian and we are excited about working with them."

"The developments in Oradea and Satu Mare are the first steps in SCD's regional expansion strategy. We are constantly looking for development opportunities in Central and South-Eastern Europe."

END

Contacts: 

Fabian Capital Limited

Mark Holdsworth

Tel: +44 20 7499 9988

Monument PR - Financial Public Relations Adviser to Fabian

Toby Moore

Tel: +44 845 355 1178

Deloitte Corporate Finance - Nominated Adviser to Fabian

James Lewis

Tel: +44 20 7936 3000

KBC Peel Hunt - Joint Broker to Fabian

Capel Irwin

Tel: +44 20 7418 8900

Shore Capital Stockbrokers Limited - Joint Broker to Fabian

Dru Danford 

Tel: +44 20 7408 4090

Notes to Editors

Fabian Romania Limited ("Fabian") is an experienced and well-known investor in the Bucharest and wider Romanian real estate market and is quoted on the London Stock Exchange's AIM. Fabian seeks to generate attractive total returns for its shareholders through a portfolio of income producing buildings, co-development projects with experienced partners and land investments. To date, Fabian has made nine investments which at 31 March 2008 had a gross market value of €127.4 million. NAV has grown 68% over the last 24 months from €1.0155 per share to €1.703 per share as at 31 March 2008.

Fabian receives investment advice from Fabian Capital Limited, an independent investment management firm that specialises in Romanian real estate investments advice. Fabian Capital does not carry out any regulated activities in the UK.

Fabian is currently jointly developing 636 apartments in the New Town scheme in East Bucharest with UK developer Mivan and 350 apartments in Timisoara with local developer Coltex. In offices, Fabian has over 40,000 square metres under development (proportionate share) in three schemes with various high quality development partners.

SCD Group is one of Hungary's most dynamically growing real estate developers and investment companies, which to date has developed a total of 181,500 square metres of residential, commercial and leisure properties with a total investment value of 210 million. These developments include over 1,000 residential units, three four-star wellness hotels, the largest aquapark in Hungary as well retail and office space. For further information on SCD Group, see www.scdgroup.hu/en

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAXKEFFAPEFE
Date   Source Headline
2nd Jun 20267:00 amRNSExercise of options and total voting rights
11th May 20263:06 pmRNSHolding(s) in Company
11th May 202611:05 amRNSGrant of patent in Japan
5th May 20267:00 amRNSYear-end trading statement
30th Mar 20267:00 amRNSAntibody IP transfer agreement
17th Feb 202611:42 amRNSDirector/PDMR Shareholding
4th Feb 20263:27 pmRNSHolding(s) in Company
2nd Feb 202611:33 amRNSHolding(s) in Company
30th Jan 20265:00 pmRNSTotal Voting Rights
27th Jan 20267:05 amRNSIssue of Director Shares
27th Jan 20267:00 amRNSPlacing and Subscription to raise approx £1.4m
19th Dec 20257:00 amRNSUpdate on negotiations with NCI regarding OptiMAL
19th Dec 20257:00 amRNSUpdate on negotiations with NCI regarding OptiMAL
16th Dec 202511:04 amRNSLaunch of OptiMAL platform
11th Dec 20257:00 amRNS-RMammalian Display video
25th Nov 202512:11 pmRNSHolding(s) in Company
24th Nov 20257:00 amRNSHalf-year Financial Report
21st Nov 20257:00 amRNSNotice of Results
13th Nov 20257:00 amRNS-ROptiMAL Library video
3rd Nov 20257:00 amRNSOptiMAL® R&D Update
27th Oct 20253:38 pmRNSHolding(s) in Company
16th Oct 20251:31 pmRNSResult of AGM
16th Oct 20257:00 amRNSAGM statement and H1 trading update
8th Oct 20257:00 amRNSContract win
19th Sep 202512:58 pmRNSPosting of Annual Report & Notice of AGM
17th Sep 20257:00 amRNSOptiMAL R&D Update
8th Sep 20257:00 amRNS-RBelfast investor presentation
4th Sep 20257:00 amRNSFinal Results
28th Aug 20257:00 amRNSContract Win
27th Aug 20257:00 amRNSContract wins with existing client
26th Aug 20257:00 amRNS-RInvestor presentations
5th Aug 20257:00 amRNSGrant of U.S. Patent for OptiMAL
24th Jul 202510:56 amRNSIssue Notification: US Patent Update
11th Jul 20257:00 amRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSTotal Voting Rights
22nd May 20252:33 pmRNSUpdate on U.S. Patent for OptiMAL®
8th May 20257:00 amRNS-RInvestor presentation
7th May 20257:00 amRNSIssue of shares to non-executive directors
6th May 202510:53 amRNSDirector/PDMR Shareholding
6th May 202510:38 amRNSHolding(s) in Company
6th May 20257:00 amRNSTrading update
30th Apr 20255:00 pmRNSTotal Voting Rights
24th Apr 20257:00 amRNSApproval of grant funding
11th Apr 202510:40 amRNSHolding(s) in Company
10th Apr 202512:47 pmRNSHolding(s) in Company
7th Apr 202512:35 pmRNSResult of General Meeting
31st Mar 20255:00 pmRNSTotal Voting Rights
24th Mar 20254:38 pmRNSHolding(s) in Company
18th Mar 20257:00 amRNSPlacing to raise approximately £1.17 million
27th Feb 20257:00 amRNSContract win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.